147 related articles for article (PubMed ID: 15845532)
21. Reduced in vivo cytotoxicity and increased Mycobacterial burden are associated with virulent Mycobacterium tuberculosis strains during lung infection.
Quintero-Macías L; Silva-Sánchez A; Valderrabano-Ortíz E; Munguía-Fuentes R; Aguilar-León D; Hernández-Pando R; Flores-Romo L
Immunol Invest; 2012; 41(1):51-60. PubMed ID: 21635179
[TBL] [Abstract][Full Text] [Related]
22. CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis.
Saunders BM; Frank AA; Orme IM; Cooper AM
Cell Immunol; 2002; 216(1-2):65-72. PubMed ID: 12381351
[TBL] [Abstract][Full Text] [Related]
23. Pathological and immunological profiles of rat tuberculosis.
Sugawara I; Yamada H; Mizuno S
Int J Exp Pathol; 2004 Jun; 85(3):125-34. PubMed ID: 15255966
[TBL] [Abstract][Full Text] [Related]
24. Initiation of acquired immunity in the lungs of mice lacking lymph nodes after infection with aerosolized Mycobacterium tuberculosis.
Kashino SS; Vallerskog T; Martens G; Troudt J; Keyser A; Taylor J; Izzo A; Kornfeld H; Campos-Neto A
Am J Pathol; 2010 Jan; 176(1):198-204. PubMed ID: 20008132
[TBL] [Abstract][Full Text] [Related]
25. Increase in gamma interferon-secreting CD8(+), as well as CD4(+), T cells in lungs following aerosol infection with Mycobacterium tuberculosis.
Feng CG; Bean AG; Hooi H; Briscoe H; Britton WJ
Infect Immun; 1999 Jul; 67(7):3242-7. PubMed ID: 10377097
[TBL] [Abstract][Full Text] [Related]
26. T cell-mediated host immune defenses in the lung.
Chen K; Kolls JK
Annu Rev Immunol; 2013; 31():605-33. PubMed ID: 23516986
[TBL] [Abstract][Full Text] [Related]
27. The host immune response to tuberculosis.
Schluger NW; Rom WN
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):679-91. PubMed ID: 9517576
[No Abstract] [Full Text] [Related]
28. Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice.
Roy E; Stavropoulos E; Brennan J; Coade S; Grigorieva E; Walker B; Dagg B; Tascon RE; Lowrie DB; Colston MJ; Jolles S
Infect Immun; 2005 Sep; 73(9):6101-9. PubMed ID: 16113331
[TBL] [Abstract][Full Text] [Related]
29. [Research progress of pulmonary tuberculosis local immune].
Hou J; Cheng X; Zhang L; Sun W
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Feb; 37(2):119-21. PubMed ID: 24796594
[No Abstract] [Full Text] [Related]
30. P2X7 modulatory web in Trypanosoma cruzi infection.
Cascabulho CM; Menna-Barreto RF; Coutinho-Silva R; Persechini PM; Henriques-Pons A
Parasitol Res; 2008 Sep; 103(4):829-38. PubMed ID: 18604654
[TBL] [Abstract][Full Text] [Related]
31. Complement factor C7 contributes to lung immunopathology caused by Mycobacterium tuberculosis.
Welsh KJ; Lewis CT; Boyd S; Braun MC; Actor JK
Clin Dev Immunol; 2012; 2012():429675. PubMed ID: 22973398
[TBL] [Abstract][Full Text] [Related]
32. Bacterial subversion of cAMP signalling inhibits cathelicidin expression, which is required for innate resistance to Mycobacterium tuberculosis.
Gupta S; Winglee K; Gallo R; Bishai WR
J Pathol; 2017 May; 242(1):52-61. PubMed ID: 28097645
[TBL] [Abstract][Full Text] [Related]
33. Stable T-cell population expressing an effector cell surface phenotype in the lungs of mice chronically infected with Mycobacterium tuberculosis.
Junqueira-Kipnis AP; Turner J; Gonzalez-Juarrero M; Turner OC; Orme IM
Infect Immun; 2004 Jan; 72(1):570-5. PubMed ID: 14688138
[TBL] [Abstract][Full Text] [Related]
34. Function of ssDNA aptamer and aptamer pool against Mycobacterium tuberculosis in a mouse model.
Chen F; Zhou J; Huang YH; Huang FY; Liu Q; Fang Z; Yang S; Xiong M; Lin YY; Tan GH
Mol Med Rep; 2013 Feb; 7(2):669-73. PubMed ID: 23242377
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary infection with hypervirulent Mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis.
Amaral EP; Ribeiro SC; Lanes VR; Almeida FM; de Andrade MR; Bomfim CC; Salles EM; Bortoluci KR; Coutinho-Silva R; Hirata MH; Alvarez JM; Lasunskaia EB; D'Império-Lima MR
PLoS Pathog; 2014 Jul; 10(7):e1004188. PubMed ID: 24991816
[TBL] [Abstract][Full Text] [Related]
36. Persistent infection with virulent but not avirulent Mycobacterium tuberculosis in the lungs of mice causes progressive pathology.
Dunn PL; North RJ
J Med Microbiol; 1996 Aug; 45(2):103-9. PubMed ID: 8683545
[TBL] [Abstract][Full Text] [Related]
37. Different innate ability of I/St and A/Sn mice to combat virulent Mycobacterium tuberculosis: phenotypes expressed in lung and extrapulmonary macrophages.
Majorov KB; Lyadova IV; Kondratieva TK; Eruslanov EB; Rubakova EI; Orlova MO; Mischenko VV; Apt AS
Infect Immun; 2003 Feb; 71(2):697-707. PubMed ID: 12540548
[TBL] [Abstract][Full Text] [Related]
38. Role of CD8+ T lymphocytes in control of Mycobacterium tuberculosis infection.
Grotzke JE; Lewinsohn DM
Microbes Infect; 2005 Apr; 7(4):776-88. PubMed ID: 15823514
[TBL] [Abstract][Full Text] [Related]
39. Alcohol exacerbates murine pulmonary tuberculosis.
Mason CM; Dobard E; Zhang P; Nelson S
Infect Immun; 2004 May; 72(5):2556-63. PubMed ID: 15102763
[TBL] [Abstract][Full Text] [Related]
40. The LFA-1 adhesion molecule is required for protective immunity during pulmonary Mycobacterium tuberculosis infection.
Ghosh S; Chackerian AA; Parker CM; Ballantyne CM; Behar SM
J Immunol; 2006 Apr; 176(8):4914-22. PubMed ID: 16585587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]